BAIDA GROUP(SH:600865)2015-10-30 16:00Financial Performance - Operating income for the first nine months rose by 9.22% to CNY 752,524,510.49 compared to the same period last year[6]. - Net profit attributable to shareholders increased by 35.06% to CNY 64,506,500.44 compared to the same period last year[7]. - Basic earnings per share decreased by 18.34% to CNY 0.2760[7]. - Total operating revenue for Q3 2015 reached ¥222,589,680.69, a 38.1% increase from ¥161,211,567.69 in Q3 2014[32]. - Net profit attributable to shareholders for Q3 2015 was ¥37,749,805.41, representing an increase of 8.8% compared to ¥34,702,885.48 in Q3 2014[34]. - Earnings per share for Q3 2015 was ¥0.100, compared to ¥0.092 in Q3 2014, reflecting an increase of 8.7%[35]. - For the first nine months of 2015, total operating revenue was ¥752,524,510.49, a 9.2% increase from ¥688,989,638.64 in the same period of 2014[32]. - Operating profit for Q3 2015 was ¥48,330,981.39, an increase of 14.4% from ¥42,279,896.35 in Q3 2014[33]. Cash Flow - Net cash flow from operating activities surged by 775.99% to CNY 18,006,709.91 year-to-date[6]. - Operating cash flow for the first nine months of 2015 was ¥18.01 million, significantly up from ¥2.06 million in the previous year, indicating an increase of approximately 775.5%[39]. - Total cash inflow from operating activities reached ¥879.92 million, compared to ¥791.50 million in the same period last year, reflecting a growth of about 11.1%[39]. - Cash outflow from operating activities was ¥861.92 million, up from ¥789.45 million, marking an increase of approximately 9.2%[39]. - Cash flow from financing activities showed a net outflow of ¥200.68 million, compared to a net outflow of ¥1.10 billion in the previous year, indicating an improvement of about 81.7%[40]. - The ending cash and cash equivalents balance was ¥145.07 million, down from ¥344.42 million at the end of the previous year, reflecting a decrease of approximately 57.9%[40]. Assets and Liabilities - Total assets decreased by 7.27% to CNY 1,725,148,877.51 compared to the end of the previous year[6]. - Total current assets decreased from CNY 1,147,131,227.82 at the beginning of the year to CNY 593,858,667.71, a decline of approximately 48.2%[26]. - Total liabilities decreased from CNY 522,316,687.98 to CNY 283,188,223.74, a reduction of about 45.8%[28]. - Owner's equity increased from CNY 1,338,105,850.54 to CNY 1,441,960,653.77, reflecting a growth of approximately 7.7%[28]. - Non-current assets rose from CNY 713,291,310.70 to CNY 1,131,290,209.80, an increase of about 58.5%[27]. Investments and Shareholder Information - The company signed a cooperation agreement with Zhejiang Provincial Cancer Hospital to establish the Zhejiang Xizi International Medical Center, aiming to provide comprehensive cancer treatment services[20]. - The company has engaged in trust investments, purchasing trust products with amounts including RMB 52 million and RMB 10 million at interest rates of 10.00% and 9.20% respectively[23]. - The company’s controlling shareholder, Xizi International Holdings, increased its stake in the company through market purchases on July 15 and September 1, 2015[23]. - The number of shareholders reached 27,858 at the end of the reporting period[11]. - The largest shareholder, Xizi International Holdings, holds 30.00% of the shares[11]. Operational Costs and Expenses - Operating costs increased by 5.26% to ¥522,945,262.05 from ¥496,830,797.31[15]. - Total operating costs for Q3 2015 were ¥179,918,857.18, up 40.8% from ¥127,783,649.48 in Q3 2014[33]. - Financial expenses decreased by 37.74% to ¥2,014,016.02 from ¥3,234,713.94[15]. - The financial expenses for Q3 2015 were ¥835,466.12, an increase of 67.9% compared to ¥497,575.61 in Q3 2014[33]. Inventory and Receivables - Accounts receivable increased by 110.84% to ¥23,051,603.46 from ¥10,933,030.25[13]. - The company reported a significant increase in inventory from CNY 1,784,961.87 to CNY 2,492,515.54, representing a growth of about 39.5%[26]. - Prepaid expenses increased by 605.71% to ¥7,692,244.13 from ¥1,089,996.81[13].